Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy

Relative Effectiveness of Osteoporosis Drugs for Preventing Nonvertebral Fracture

(2013) Suzanne M. Cadarette et al.   ANNALS OF INTERNAL MEDICINE

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008

(2010) Ethel S Siris et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: The eValuation of IBandronate Efficacy (VIBE) database fracture study

(2009) S.T. Harris et al.   BONE

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction

(2008) J. R. Curtis et al.   OSTEOPOROSIS INTERNATIONAL

Secular trends in hip fracture incidence and recurrence

(2008) L. J. Melton et al.   OSTEOPOROSIS INTERNATIONAL